You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信立泰(002294.SZ):紅杉瀚辰、太嘉杉合夥等擬投資入股金仕生物
格隆匯 11-18 17:38

格隆匯11月18日丨信立泰(002294.SZ)公佈,金仕生物科技(常熟)有限公司(“金仕生物”或“標的公司”)系公司全資子公司深圳市信立泰生物醫療工程有限公司(“生物醫療”)的參股公司,生物醫療持有金仕生物10.1081%股權。為支持金仕生物引入新投資者,生物醫療擬將其持有的金仕生物合計1.5789%股權轉讓給深圳市紅杉瀚辰股權投資合夥企業(有限合夥)(“紅杉瀚辰”)、太嘉杉健康產業股權投資基金(上海)合夥企業(有限合夥)(“太嘉杉合夥”),股權轉讓款合計為人民幣3000萬元。

此外,紅杉瀚辰、太嘉杉合夥、光潤歆醫(天津)健康產業股權投資合夥企業(有限合夥)(“光潤歆醫”)、廣發乾和投資有限公司(“廣發乾和”)、杭州磐霖旭康創業投資合夥企業(有限合夥)(“磐霖旭康”)(下合稱“增資方”)擬以人民幣29000萬元向金仕生物增資,獲得其13.2419%股權;生物醫療及金仕生物其他現有股東擬放棄此次增資的優先認繳權。

轉讓股權暨放棄增資優先認繳權前,生物醫療持有金仕生物10.1081%股權;有關事項完成後,生物醫療將持有金仕生物7.3997%股權。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account